# üéØ SPORADIC CANCER STRATEGY - MASTER INDEX

**Mission**: Complete workflow for sporadic (germline-negative) cancers  
**Coverage**: 85-90% of all cancer cases  
**Status**: ‚öîÔ∏è **MODULARIZED FOR EXECUTION**

---

## üìö **MODULAR STRUCTURE**

### **Core Strategy**
- **`01_EXECUTIVE_SUMMARY.mdc`** - Vision, prevalence, strategic shift
- **`02_PARADIGM_SHIFT.mdc`** - Germline‚ÜíTumor pivot, what changes

### **Technical Implementation**
- **`03_PLATFORM_INTEGRATION.mdc`** - S/P/E + SAE + Treatment Lines
- **`04_TUMOR_NGS_INGESTION.mdc`** - Foundation/Tempus parsers
- **`05_CLINICAL_TRIAL_MATCHING.mdc`** - Sporadic-aware filtering
- **`06_FRONTEND_UI.mdc`** - Germline banner, NGS upload, trial cards

### **Execution**
- **`07_BUILD_PLAN.mdc`** - 7-day implementation, endpoints, acceptance
- **`08_BACKEND_CONTRACTS.mdc`** - Schemas, endpoints, provenance
- **`09_WIWFM_SPORADIC.mdc`** - Efficacy prediction for sporadic cases

### **Reference**
- **`10_AYESHA_CASE_STUDY.mdc`** - Real-world example
- **`11_PATIENT_REPORTS.mdc`** - Templates for patients/providers
- **`12_SMOKE_TESTS.mdc`** - 4 test scenarios with acceptance

---

## üéØ **QUICK START**

### **If You're Building Tumor NGS Ingestion**:
1. Read `04_TUMOR_NGS_INGESTION.mdc`
2. Implement Foundation/Tempus parsers
3. Test with sample reports
4. Integrate with WIWFM

### **If You're Building WIWFM for Sporadic**:
1. Read `09_WIWFM_SPORADIC.mdc`
2. Add germline gating logic
3. Integrate tumor context
4. Test PARP penalty + TMB boost

---

## üìä **CURRENT STATUS**

| Module | Status | Next Action |
|--------|--------|-------------|
| Paradigm Shift | üü¢ Documented | Execute build |
| Platform Integration | üü° Partially done | Add germline gating |
| Tumor NGS | üî¥ Not Started | Build parsers |
| Clinical Trials | üü° Partially done | Add sporadic filters |
| Frontend UI | üî¥ Not Started | Build banner + upload |

---

**STRATEGIC VALUE**: Address 85-90% of cancer cases (sporadic) vs 10-15% (hereditary)

**COMPETITIVE ADVANTAGE**: Most platforms focus on hereditary, we focus on sporadic

---

**NEXT**: Read `01_EXECUTIVE_SUMMARY.mdc` for vision
